F8 and hemophilia A: Although the A2 and C2 domains are considered the immunodominant domains, a polyclonal response consisting of neutralizing and non-neutralizing antibodies targeting functional and non-functional FVIII epitopes has been described in patients with congenital and acquired hemophilia A and in hemophilia A mice (8–12).